RBC Capital Starts EyePoint Pharmaceuticals, Inc. (EYPT) at Outperform
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Price: $14.13 +4.82%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Lisa Walter initiates coverage on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) with a Outperform rating and a price target of $28.00.
For an analyst ratings summary and ratings history on EyePoint Pharmaceuticals, Inc. click here. For more ratings news on EyePoint Pharmaceuticals, Inc. click here.
Shares of EyePoint Pharmaceuticals, Inc. closed at $8.90 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
